02.12.20|Meir OrbachChina's Fosun Pharma, insurance company Ping-An and four large Chinese funds all took part in the round
22.09.20|Meir OrbachThe agreement provides JuveStar with exclusive rights to develop and commercialize Raziel Therapeutics’ proprietary RZL-012 compound
04.07.19|Golan HazaniFosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013
10.12.18|Dotan LevyThe ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers
28.11.18|Golan HazaniSisram Medical, formerly Alma Lasers, is buying Nova Medical, one of the largest distributors of medical aesthetic devices in Israel
08.11.17|Lilach BaumerThe Israel-based company develops a valve implant that can be installed through thigh catheterization instead of invasive heart surgery
19.09.17|Amarelle WenkertThe Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
10.09.17|Amarelle WenkertOn September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange